Recently, the Department of Health and Human Services released new data that confirms that for the first time ever, three individuals in the United States have received financial compensation from the federal government’s injury compensation program, specifically the Countermeasures Injury Compensation Program (CICP), for injuries sustained from the COVID-19 vaccine. The amounts of compensation received by the individuals were a fat $2019 for anaphylaxis (allergic shock), $1582 for myocarditis (inflammation of the heart muscle), and $1032.69 for the same condition.
However, the relatively low sums of compensation received by the individuals were only for unreimbursed medical expenses, and not for lost income, according to Mr. Wayne Road, who published a book called “The Vaccine Court.”
It’s worth noting that there are two different compensation funds in the US: the CICP and the Vaccine Injury Compensation Program (VICP). While the VICP is specifically designed for vaccine injuries, it does not cover COVID-19 vaccine-induced injuries as the vaccine is classified as a countermeasure under the CICP. Despite the fact that the COVID-19 pandemic has ended and the Pfizer vaccine has received FDA approval, people who suffer from COVID-19 vaccine-induced injuries can still only receive compensation from the CICP.
The distinction between the CICP and VICP matters because the VICP is funded directly by pharmaceutical companies, while the CICP is not. The CICP covers countermeasures, which must be qualified pandemic or epidemic products or security countermeasures or drugs, biological products, or devices authorized for investigational or emergency use.